{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:04:51Z","timestamp":1761102291522},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,9,7]],"date-time":"2017-09-07T00:00:00Z","timestamp":1504742400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s12328-017-0772-x","type":"journal-article","created":{"date-parts":[[2017,9,7]],"date-time":"2017-09-07T09:58:57Z","timestamp":1504778337000},"page":"459-463","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Disappearance of multiple hyperechoic liver nodules in sporadic porphyria cutanea tarda after treatment with ledipasvir\/sofosbuvir for hepatitis C"],"prefix":"10.1007","volume":"10","author":[{"given":"Kazuhide","family":"Takata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Shakado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Kunimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Morihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuaki","family":"Takeyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Irie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Sakisaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,7]]},"reference":[{"key":"772_CR1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0190-9622(99)70402-0","volume":"41","author":"TY Chuang","year":"1999","unstructured":"Chuang TY, Brashear R, Lewis C. Porphyria cutanea tarda and hepatitis C virus: a case-control study and meta-analysis of the literature. J Am Acad Dermatol. 1999;41:31\u20136.","journal-title":"J Am Acad Dermatol"},{"key":"772_CR2","first-page":"190","volume":"7","author":"E Dabrowska","year":"2001","unstructured":"Dabrowska E, Jablonska-Kaszewska I, Bielawski KP, et al. Influence of hepatitis C virus (HCV) infection on porphyrin and iron metabolism in porphyria cutanea tarda (PCT) patients. Med Sci Monit. 2001;7:190\u20136.","journal-title":"Med Sci Monit"},{"key":"772_CR3","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0168-8278(03)00346-5","volume":"39","author":"JP Gisbert","year":"2003","unstructured":"Gisbert JP, Garcia-Buey L, Pajares JM, et al. Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis. J Hepatol. 2003;39:620\u20137.","journal-title":"J Hepatol"},{"key":"772_CR4","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/hep.1840160603","volume":"16","author":"S Fargion","year":"1992","unstructured":"Fargion S, Piperno A, Cappellini MD, et al. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology. 1992;16:1322\u20136.","journal-title":"Hepatology"},{"key":"772_CR5","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1478-3231.2012.02794.x","volume":"32","author":"F Ryan Caballes","year":"2012","unstructured":"Ryan Caballes F, Sendi H, Bonkovsky HL. Hepatitis C, porphyria cutanea tarda and liver iron: an update. Liver Int. 2012;32:880\u201393.","journal-title":"Liver Int"},{"key":"772_CR6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-2008-1048170","volume":"148","author":"W Kersjes","year":"1988","unstructured":"Kersjes W, Harder T, Steudel A, et al. Multiple circular liver foci in latent porphyria  cutanea tarda. RoFo. 1988;148:165\u20138 (in German).","journal-title":"RoFo"},{"key":"772_CR7","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/BF01721687","volume":"67","author":"WK Lelbach","year":"1989","unstructured":"Lelbach WK, Muller TR, Kersjes W, et al. Multiple nodular foci in the liver associated with chronic hepatic porphyria after previous treatment of breast cancer. Klin Wochenschr. 1989;67:592\u20137.","journal-title":"Klin Wochenschr"},{"key":"772_CR8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2957\/kanzo.30.241","volume":"30","author":"C Kawamoto","year":"1989","unstructured":"Kawamoto C, Ido K, Hitomi N, et al. A case of porphyria cutanea tarda with multiple hyperechoic lesions in the liver. Kanzo. 1989;30:241\u20136 (in Japanese).","journal-title":"Kanzo"},{"key":"772_CR9","first-page":"2669","volume":"87","author":"M Komatsu","year":"1990","unstructured":"Komatsu M, Goto M, Ishida S, et al. Three cases of chronic hepatic porphyria demonstrateing the image similar to focal fatty change in the liver. J Jpn Soc Gastroenterol. 1990;87:2669\u201374 (in Japanese).","journal-title":"J Jpn Soc Gastroenterol"},{"key":"772_CR10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF01887354","volume":"16","author":"F Flueckiger","year":"1991","unstructured":"Flueckiger F, Steiner H, Leitinger G, et al. Nodular focal fatty infiltration of the liver in acquired porphyria cutanea tarda. Gastrointest Radiol. 1991;16:237\u20139.","journal-title":"Gastrointest Radiol"},{"key":"772_CR11","first-page":"147","volume":"22","author":"H Miyachi","year":"1995","unstructured":"Miyachi H, Kubota M, Fusegawa H, et al. Focal fatty infiltration in chronic hepatic porphyria without skin lesion. Jpn J Med Ultrasonics. 1995;22:147\u201351 (in Japanese).","journal-title":"Jpn J Med Ultrasonics"},{"key":"772_CR12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0899-7071(98)00069-2","volume":"22","author":"P Chevallier","year":"1998","unstructured":"Chevallier P, Bahadoran P, Buckley MJ, et al. Hepatic multi-nodular focal fatty metamorphosis in acquired porphyria cutanea tarda. Sonographic, CT, and MRI features. Clin Imaging. 1998;22:418\u201321.","journal-title":"Clin Imaging"},{"key":"772_CR13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2957\/kanzo.40.350","volume":"40","author":"K Dohmen","year":"1999","unstructured":"Dohmen K, Onohara S, Ajibe H, et al. Chronic hepatitis C associated with porphyria cutanea tarda which showed hepatic focal fatty change arising in a non-alcoholic patient. Kanzo. 1999;40:350\u20134 (in Japanese).","journal-title":"Kanzo"},{"key":"772_CR14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2957\/kanzo.45.261","volume":"45","author":"A Saito","year":"2004","unstructured":"Saito A, Suto S, Tsuruta Y, et al. A case of multiple focal fatty change with porphyria cutanea tarda in chronic hepatitis C: improvement after interferon and ribavirin combination therapy. Kanzo. 2004;45:261\u20137 (in Japanese).","journal-title":"Kanzo"},{"key":"772_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s0026101710560","author":"M Nishiyama","year":"2017","unstructured":"Nishiyama M, Sakamoto K, Shinagawa Y, et al. A case of porphyria cutanea tarda of the liver exhibiting multifocal macrovesicular steatosis in the background of microvesicular steatosis, probably caused by uneven iron accumulation. Abdom Radiol. 2017. doi:\n                        10.1007\/s0026101710560\n                        \n                    .","journal-title":"Abdom Radiol"},{"key":"772_CR16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0781.1996.tb00241.x","volume":"12","author":"FM O\u2019Reilly","year":"1996","unstructured":"O\u2019Reilly FM, Darby C, Fogarty J, et al. Porphyrin metabolism in hepatitis C infection. Photodermatol Photoimmunol Photomed. 1996;12:31\u20133.","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"772_CR17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2230.1996.tb00095.x","volume":"21","author":"I Hussain","year":"1996","unstructured":"Hussain I, Hepburn NC, Jones A, et al. The association of hepatitis C viral infection with porphyria cutanea tarda in the Lothian region of Scotland. Clin Exp Dermatol. 1996;21:283\u20135.","journal-title":"Clin Exp Dermatol"},{"key":"772_CR18","first-page":"397","volume":"78","author":"OT Chan","year":"2006","unstructured":"Chan OT, Tsai N, Wong RL, et al. The additive effects of hepatitis C infection and end-stage renal disease in porphyria cutaneatarda. Cutis. 2006;78:397\u2013400.","journal-title":"Cutis"},{"key":"772_CR19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cgh.2009.11.017","volume":"8","author":"S Jalil","year":"2010","unstructured":"Jalil S, Grady JJ, Lee C, Anderson KE. Associations among behavior-related susceptibility factors in porphyria cutanea tarda. Clin Gastroenterol Hepatol. 2010;8:297\u2013302.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"772_CR20","first-page":"525","volume":"44","author":"J Okano","year":"1997","unstructured":"Okano J, Horie Y, Kawasaki H, et al. Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C. Hepatogastroenterology. 1997;44:525\u20138.","journal-title":"Hepatogastroenterology"},{"key":"772_CR21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0168-8278(95)80438-2","volume":"22","author":"H Takikawa","year":"1995","unstructured":"Takikawa H, Yamazaki R, Shoji S, et al. Normalization of urinary porphyrin level and disappearance of skin lesions after successful interferon therapy in a case of chronic hepatitis C complicated with porphyria cutanea tarda. J Hepatol. 1995;22:249\u201350.","journal-title":"J Hepatol"},{"key":"772_CR22","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1111\/bjd.13376","volume":"171","author":"P Aguilera","year":"2014","unstructured":"Aguilera P, Laguno M, To-Figueras J. Treatment of chronic hepatitis with boceprevir leads to remission of porphyria cutanea tarda. Br J Dermatol. 2014;171:1595\u20136.","journal-title":"Br J Dermatol"},{"key":"772_CR23","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1001\/jamadermatol.2016.3036","volume":"152","author":"Y Tong","year":"2016","unstructured":"Tong Y, Song YK, Tyring S. Resolution of porphyria cutanea tarda in patients with hepatitis C following ledipasvir\u2013sofosbuvir combination therapy. JAMA Dermatol. 2016;152:1393\u20135.","journal-title":"JAMA Dermatol"},{"key":"772_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13936","author":"MM Hatch","year":"2017","unstructured":"Hatch MM, Nawas Z, Kollipara R, et al. Can curative antivirals benefit porphyria cutanea tarda in hepatitis C patients? J Eur Acad Dermatol Venereol. 2017. doi:\n                        10.1111\/jdv.13936\n                        \n                    .","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"772_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15502","author":"A Combalia","year":"2017","unstructured":"Combalia A, To-Figueras J, Laguno M, et al. Direct-acting antivirals for hepatitis C virus induce a rapid clinical and biochemical remission of porphyria cutanea tarda. Br J Dermatol. 2017. doi:\n                        10.1111\/bjd.15502\n                        \n                    .","journal-title":"Br J Dermatol"},{"key":"772_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14186","author":"LE Wiznia","year":"2017","unstructured":"Wiznia LE, Laird ME, Franks AG Jr. Hepatitis C virus and its cutaneous manifestations: treatment in the direct-acting antiviral era. J Eur Acad Dermatol Venereol. 2017. doi:\n                        10.1111\/jdv.14186\n                        \n                    .","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12328-017-0772-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-017-0772-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-017-0772-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T13:25:25Z","timestamp":1505913925000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12328-017-0772-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,7]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["772"],"URL":"https:\/\/doi.org\/10.1007\/s12328-017-0772-x","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,7]]}}}